Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 1;63(4):532-9.
doi: 10.1097/QAI.0b013e3182968f87.

Risk factors for anal human papillomavirus infection type 16 among HIV-positive men who have sex with men in San Francisco

Affiliations

Risk factors for anal human papillomavirus infection type 16 among HIV-positive men who have sex with men in San Francisco

Alexandra L Hernandez et al. J Acquir Immune Defic Syndr. .

Abstract

Background: HIV-positive men who have sex with men (MSM) are at high risk of anal cancer compared with the general population. Human papillomavirus (HPV) infection, particularly HPV 16, is causally associated with anal cancer. However, the risk factors for anal HPV 16 infection are poorly understood. We determined the prevalence and risk factors for anal HPV 16 infection in a population of HIV-positive MSM, most of whom were being treated with antiretroviral therapy.

Design: Cross-sectional data from the baseline visit of a 4-year prospective cohort study.

Methods: Three hundred forty-eight HIV-positive MSM were recruited in San Francisco, and they received a detailed sexual behavior risk factor questionnaire. An anal swab was used to collect specimens for HPV type-specific DNA testing using L1 HPV DNA polymerase chain reaction. We used log-binomial multivariable models to determine the risk factors for anal HPV 16 infection.

Results: Ninety-two percent of HIV-positive MSM had at least 1 anal HPV type, 80% had at least 1 oncogenic HPV type, and 42% had HPV 16. Non-Hispanic white race and higher level of education were associated with a decreased risk of HPV 16 infection. A higher number of total male partners was associated with HPV 16 (relative risk: 1.6, 95% confidence interval 1.1 to 2.4, P = 0.01) for 201-1000 partners compared with 1-200. Injection drug use was independently associated with anal HPV 16 infection (relative risk: 1.5, 95% confidence interval 1.2 to 1.9, P = 0.003).

Conclusions: The prevalence of anal HPV infection, including HPV 16, is high in HIV-positive MSM. HIV-positive MSM should be counseled about the risk associated with increased partners and injection drug use.

PubMed Disclaimer

Conflict of interest statement

Financial Disclaimer/Conflict of Interest:

Hernandez AH – no potential conflict of interest to disclose

Efird JT – no potential conflict of interest to disclose

Holly EA – no potential conflict of interest to disclose

Berry JM – no potential conflict of interest to disclose

Jay N - no potential conflict of interest to disclose

Palefsky JP – no potential conflict of interest to disclose

Figures

Figure 1
Figure 1
Prevalence of HPV infection by type among HIV-positive men who have sex with men in San Francisco, CA. Figure includes only the 318 men whose anal swab specimens were β-globin DNA-positive. Men who had more than one prevalent HPV type are included in each prevalence calculation for which they were positive.

References

    1. Daling JR, Weiss NS, Hislop TG, Maden C, Coates RJ, Sherman KJ, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317:973–977. - PubMed
    1. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, et al. Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America. Clin Infect Dis. 2012 - PMC - PubMed
    1. Bower M, Palmieri C, Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis. 2006;19:14–19. - PubMed
    1. Bower M, Powles T, Newsom-Davis T, Thirlwell C, Stebbing J, Mandalia S, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr. 2004;37:1563–1565. - PubMed
    1. Chiao EY, Krown SE, Stier EA, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr. 2005;40:451–455. - PubMed

Publication types

MeSH terms

Substances